glp-1 receptor agonists weight loss What Are For Loss? The central and peripheral effects
Description
Discontinuation of GLP1RAs and tirzepatide typically results in weight regain, deterioration of glycaemic control and the loss of previous improvements in cardiometabolic markers
showed that obesity in patients with T1D is associated with an increased risk of chronic kidney disease (CKD) compared with T2D (23)
JAMA - J
doi: 10.4239/wjd.v6.i6.807 27 CarvalhoL
Interestingly, Lira has also been shown to attenuate negative feedback inhibition of bile acids by inhibiting intestinal FXR activity and ultimately reduce bile acid synthesis in the liver [76]
